BioCentury
ARTICLE | Clinical News

O6-Benzylguanine (BG): Began Phase II testing

March 27, 2000 8:00 AM UTC

Procept is a subsidiary of HeavenlyDoor.com Inc. (HVDC), and the trial is sponsored by the National Cancer Institute. ...